We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 18 start-ups with an aggregate funding of $1.6b. The average funding per company in this subset is $87.2m.
Last update to the database: Feb 18, 2025. See changelog.
3
Funding Rounds
$52.0m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
2
Funding Rounds
$1.0b
Money raised
RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.
7
Funding Rounds
$24.5m
Money raised
Immunophotonics is a company developing immunotherapy-based treatments for cancer founded in 2012 by Lu Alleruzzo.
6
Funding Rounds
$15.8m
Money raised
Scailyte is a drug discovery and molecular diagnostics company developing molecular analytical tools for clinical applications.
1
Funding Rounds
$150.0m
Money raised
Neurimmune AG is a Schlieren, Zurich-based pharmaceutical company
3
Funding Rounds
$33.5m
Money raised
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.
1
Funding Rounds
$16.9m
Money raised
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.
1
Funding Rounds
$11.1m
Money raised
A pharmaceutical company specializing in developing treatments for rare diseases
6
Funding Rounds
$6.2m
Money raised
Proprietary technology platform for the design and selection of GPCR-targeting compounds
2
Funding Rounds
$42.0m
Money raised
NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.
6
Funding Rounds
Vaccines
1
Funding Rounds
$3.0m
Money raised
Analytical testing company focused on improving people's health.
1
Funding Rounds
$1.2m
Money raised
Novigenix is a Épalinges-based molecular diagnostics company developing blood tests for early detection of cancer founded in 2014.
1
Funding Rounds
$55.0m
Money raised
NousCom is a cancer Immunotherapies founded in 2015.
2
Funding Rounds
$100.0m
Money raised
Therachon is a company founded in 2014.
1
Funding Rounds
$11.7m
Money raised
Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .
1
Funding Rounds
$27.5m
Money raised
Azafaros is a small Molecules.
1
Funding Rounds
$1.1m
Money raised
Laeverdoc is a Switzerland-based company.
Enter your email and get access to 71,000 + technology companies you can partner with.